Centro Ricerca Tettamanti Pediatric Clinic University of Milano Bicocca Monza Italy

Children's Cancer Research Institute Vienna Austria

CLIP Department of Paediatric Haematology Oncology Charles University Prague 2nd Faculty of Medicine Prague Czech Republic

Department of Advanced Diagnosis Clinical Research Center National Hospital Organization Nagoya Medical Center Nagoya Japan

Department of Clinical Sciences Pediatrics Umeå University Umeå Sweden

Department of Genetics Robert Debré Hospital and University of Paris Paris France

Department of Pediatric Hematology and Oncology Research National Research Institute for Child Health and Development Tokyo Japan

Department of Pediatric Oncology Hematology and Diabetology Medical University of Łódź Poland CA Poland

Department of Pediatrics Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center University of California San Francisco San Francisco CA USA

Department of Pediatrics Christian Albrechts University Kiel and University Medical Center Schleswig Holstein Kiel Germany

Department of Pediatrics Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

Department of Pediatrics Hokkaido University Graduate School of Medicine Sapporo Japan

Division of Hematology Oncology Chang Gung Memorial Hospital at Linkou and Chang Gung University Taoyuan Taiwan

Hannover Medical School Institute of Human Genetics Hannover Germany

Khoo Teck Puat National University Children's Medical Institute Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

Leukaemia Research Cytogenetics Group Wolfson Childhood Cancer Research Centre Translational and Clinical Research Institute Newcastle University Newcastle upon Tyne UK

Oncode Institute Utrecht Netherlands

Princess Máxima Center for Pediatric Oncology Utrecht Netherlands

St Jude Children's Research Hospital and Department of Pediatrics College of Medicine The University of Tennessee Health Science Center Memphis TN USA

Zobrazit více v PubMed

Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373:1541–52. doi: 10.1056/NEJMra1400972. PubMed DOI

Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, et al. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. Nat. Genet. 2016;48:569–74. doi: 10.1038/ng.3535. PubMed DOI

Liu YF, Wang BY, Zhang WN, Huang JY, Li BS, Zhang M, et al. Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine. 2016;8:173–83. doi: 10.1016/j.ebiom.2016.04.038. PubMed DOI PMC

Hirabayashi S, Ohki K, Nakabayashi K, Ichikawa H, Momozawa Y, Okamura K, et al. ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype. Haematologica. 2017;102:118–29. doi: 10.3324/haematol.2016.151035. PubMed DOI PMC

Li JF, Dai YT, Lilljebjorn H, Shen SH, Cui BW, Bai L, et al. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Proc Natl Acad Sci USA. 2018;115:E11711–E20. doi: 10.1073/pnas.1814397115. PubMed DOI PMC

Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, et al. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019;51:296–307. doi: 10.1038/s41588-018-0315-5. PubMed DOI PMC

Zaliova M, Stuchly J, Winkowska L, Musilova A, Fiser K, Slamova M, et al. Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort. Haematologica. 2019;104:1396–406. doi: 10.3324/haematol.2018.204974. PubMed DOI PMC

Alexander TB, Gu Z, Iacobucci I, Dickerson K, Choi JK, Xu B, et al. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature. 2018;562:373–9. doi: 10.1038/s41586-018-0436-0. PubMed DOI PMC

Hrusak O, de Haas V, Stancikova J, Vakrmanova B, Janotova I, Mejstrikova E, et al. International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. Blood. 2018;132:264–76. doi: 10.1182/blood-2017-12-821363. PubMed DOI

Steeghs EMP, Boer JM, Hoogkamer AQ, Boeree A, de Haas V, de Groot-Kruseman HA, et al. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia. Sci Rep. 2019;9:4634. doi: 10.1038/s41598-019-41078-4. PubMed DOI PMC

Bueno C, Tejedor JR, Bashford-Rogers R, Gonzalez-Silva L, Valdes-Mas R, Agraz-Doblas A, et al. Natural history and cell of origin of TC F3-ZN F384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL. Blood. 2019;134:900–5. doi: 10.1182/blood.2019000893. PubMed DOI

Greaves M. A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2018;18:471–84. doi: 10.1038/s41568-018-0015-6. PubMed DOI PMC

Novakova M, Zaliova M, Fiser K, Vakrmanova B, Slamova L, Musilova A, et al. DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch. Haematologica. 2020. PubMed PMC

Oberley MJ, Gaynon PS, Bhojwani D, Pulsipher MA, Gardner RA, Hiemenz MC, et al. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia. Pediatr Blood Cancer. 2018;65:e27265. doi: 10.1002/pbc.27265. PubMed DOI PMC

Nishimura A, Hasegawa D, Hirabayashi S, Kanabuchi S, Yamamoto K, Aiga S, et al. Very late relapse cases of TCF3-ZNF384-positive acute lymphoblastic leukemia. Pediatr Blood Cancer. 2019;66:e27891. doi: 10.1002/pbc.27891. PubMed DOI

Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group

A novel class of ZNF384 aberrations in acute leukemia